| Dr Christopher Hugh Warner, MD | |
|
1061 Harmon Ave, Fort Stewart, GA 31314-5641 | |
| (912) 435-6965 | |
| Not Available |
| Full Name | Dr Christopher Hugh Warner |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1061 Harmon Ave, Fort Stewart, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447231352 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01055246A (Indiana) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 01055246A (Indiana) | Primary |
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
CANCER RESEARCH UK scientists have discovered how a protein in immune cells plays an essential role in their development by repairing DNA damage - and if this protein is missing lymphomas can form.
VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.
The Montreal Heart Institute announces that the COLCORONA study results are published today in The Lancet Respiratory Medicine.
Crescendo Bioscience announced today the commercial launch of Vectra DA, its first-in-class multi-biomarker blood test designed to aid physicians in managing patients with rheumatoid arthritis (RA). Vectra DA analyzes 12 key serum biomarkers to produce a single objective score that quantifies RA disease activity.
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Hugh Warner, MD 1061 Harmon Ave, Fort Stewart, GA 31314-5641 Ph: (912) 435-6965 | Dr Christopher Hugh Warner, MD 1061 Harmon Ave, Fort Stewart, GA 31314-5641 Ph: (912) 435-6965 |
News Archive
CANCER RESEARCH UK scientists have discovered how a protein in immune cells plays an essential role in their development by repairing DNA damage - and if this protein is missing lymphomas can form.
VisionGate Inc., an in vitro diagnostics company that is developing a revolutionary, non-invasive test for the early detection of lung cancer and other applications, announced that positive results from a clinical study of its LuCED lung test will be highlighted in a poster presentation (Abstract #7547) during the American Society of Clinical Oncology (ASCO) 2014 Annual Meeting at McCormick Place in Chicago on Saturday, May 31, 1:15 to 5 p.m. in S Hall A2, poster board 155.
The Montreal Heart Institute announces that the COLCORONA study results are published today in The Lancet Respiratory Medicine.
Crescendo Bioscience announced today the commercial launch of Vectra DA, its first-in-class multi-biomarker blood test designed to aid physicians in managing patients with rheumatoid arthritis (RA). Vectra DA analyzes 12 key serum biomarkers to produce a single objective score that quantifies RA disease activity.
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
› Verified 8 days ago
Dr. Robert Difilippo, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-3600 | |
Dr. Natalya Chernyak, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1061 Harmon Ave, Fort Stewart, GA 31314 Phone: 912-435-6633 | |
Dr. Charmaine C. Ramsay-thomas, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1061 Harmon Ave, Ste1d03, Fort Stewart, GA 31314 Phone: 912-767-1133 Fax: 912-767-5271 | |
Dr. Earnestine Watson Otovo, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave Ste 1d03, Fort Stewart, GA 31314 Phone: 912-435-6633 | |
Dr. Brian David Quint, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Ebh 3sb, 952 William H. Wilson Avenue, Building 607, Fort Stewart, GA 31324 Phone: 912-435-2335 | |
Dr. Sanjana Karim, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1061 Harmon Ave, Suite 1d03, Fort Stewart, GA 31314 Phone: 912-435-6633 | |
Dr. William Gerald Bissell, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1061 Harmon Ave Ste 1d03, Fort Stewart, GA 31314 Phone: 912-435-5965 |